nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobutrol—Sweating increased—Delavirdine—acquired immunodeficiency syndrome	0.00483	0.00483	CcSEcCtD
Gadobutrol—Dysgeusia—Stavudine—acquired immunodeficiency syndrome	0.00463	0.00463	CcSEcCtD
Gadobutrol—Dry mouth—Didanosine—acquired immunodeficiency syndrome	0.00453	0.00453	CcSEcCtD
Gadobutrol—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00444	0.00444	CcSEcCtD
Gadobutrol—Infection—Didanosine—acquired immunodeficiency syndrome	0.00441	0.00441	CcSEcCtD
Gadobutrol—Paraesthesia—Amprenavir—acquired immunodeficiency syndrome	0.00438	0.00438	CcSEcCtD
Gadobutrol—Hypoaesthesia—Indinavir—acquired immunodeficiency syndrome	0.00437	0.00437	CcSEcCtD
Gadobutrol—Sweating increased—Saquinavir—acquired immunodeficiency syndrome	0.0043	0.0043	CcSEcCtD
Gadobutrol—Pollakiuria—Ritonavir—acquired immunodeficiency syndrome	0.00423	0.00423	CcSEcCtD
Gadobutrol—Vertigo—Abacavir—acquired immunodeficiency syndrome	0.00418	0.00418	CcSEcCtD
Gadobutrol—Hypoaesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00413	0.00413	CcSEcCtD
Gadobutrol—Convulsion—Nelfinavir—acquired immunodeficiency syndrome	0.00411	0.00411	CcSEcCtD
Gadobutrol—Sweating increased—Lamivudine—acquired immunodeficiency syndrome	0.0041	0.0041	CcSEcCtD
Gadobutrol—Convulsion—Abacavir—acquired immunodeficiency syndrome	0.00403	0.00403	CcSEcCtD
Gadobutrol—Dysgeusia—Zidovudine—acquired immunodeficiency syndrome	0.00402	0.00402	CcSEcCtD
Gadobutrol—Visual impairment—Efavirenz—acquired immunodeficiency syndrome	0.004	0.004	CcSEcCtD
Gadobutrol—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.00399	0.00399	CcSEcCtD
Gadobutrol—Paraesthesia—Didanosine—acquired immunodeficiency syndrome	0.00399	0.00399	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.00399	0.00399	CcSEcCtD
Gadobutrol—Hypoaesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00395	0.00395	CcSEcCtD
Gadobutrol—Dry mouth—Stavudine—acquired immunodeficiency syndrome	0.00394	0.00394	CcSEcCtD
Gadobutrol—Pollakiuria—Lamivudine—acquired immunodeficiency syndrome	0.00389	0.00389	CcSEcCtD
Gadobutrol—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.00385	0.00385	CcSEcCtD
Gadobutrol—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.0038	0.0038	CcSEcCtD
Gadobutrol—Pain—Didanosine—acquired immunodeficiency syndrome	0.0038	0.0038	CcSEcCtD
Gadobutrol—Infection—Abacavir—acquired immunodeficiency syndrome	0.00377	0.00377	CcSEcCtD
Gadobutrol—Dysgeusia—Indinavir—acquired immunodeficiency syndrome	0.00374	0.00374	CcSEcCtD
Gadobutrol—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.00374	0.00374	CcSEcCtD
Gadobutrol—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.00373	0.00373	CcSEcCtD
Gadobutrol—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.00369	0.00369	CcSEcCtD
Gadobutrol—Hypoaesthesia—Ritonavir—acquired immunodeficiency syndrome	0.00365	0.00365	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.00363	0.00363	CcSEcCtD
Gadobutrol—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.00359	0.00359	CcSEcCtD
Gadobutrol—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.00356	0.00356	CcSEcCtD
Gadobutrol—Visual impairment—Ritonavir—acquired immunodeficiency syndrome	0.00354	0.00354	CcSEcCtD
Gadobutrol—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.00353	0.00353	CcSEcCtD
Gadobutrol—Hypoaesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00351	0.00351	CcSEcCtD
Gadobutrol—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.00351	0.00351	CcSEcCtD
Gadobutrol—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00351	0.00351	CcSEcCtD
Gadobutrol—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.0035	0.0035	CcSEcCtD
Gadobutrol—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.00349	0.00349	CcSEcCtD
Gadobutrol—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.00347	0.00347	CcSEcCtD
Gadobutrol—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.00346	0.00346	CcSEcCtD
Gadobutrol—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00345	0.00345	CcSEcCtD
Gadobutrol—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.00344	0.00344	CcSEcCtD
Gadobutrol—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.00343	0.00343	CcSEcCtD
Gadobutrol—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00342	0.00342	CcSEcCtD
Gadobutrol—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.00341	0.00341	CcSEcCtD
Gadobutrol—Visual impairment—Saquinavir—acquired immunodeficiency syndrome	0.0034	0.0034	CcSEcCtD
Gadobutrol—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00339	0.00339	CcSEcCtD
Gadobutrol—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.00338	0.00338	CcSEcCtD
Gadobutrol—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.00338	0.00338	CcSEcCtD
Gadobutrol—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00335	0.00335	CcSEcCtD
Gadobutrol—Hypoaesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00335	0.00335	CcSEcCtD
Gadobutrol—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00333	0.00333	CcSEcCtD
Gadobutrol—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00331	0.00331	CcSEcCtD
Gadobutrol—Pain—Stavudine—acquired immunodeficiency syndrome	0.0033	0.0033	CcSEcCtD
Gadobutrol—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00327	0.00327	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.00327	0.00327	CcSEcCtD
Gadobutrol—Pain—Abacavir—acquired immunodeficiency syndrome	0.00325	0.00325	CcSEcCtD
Gadobutrol—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.00324	0.00324	CcSEcCtD
Gadobutrol—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00324	0.00324	CcSEcCtD
Gadobutrol—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.00319	0.00319	CcSEcCtD
Gadobutrol—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.00318	0.00318	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00316	0.00316	CcSEcCtD
Gadobutrol—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00316	0.00316	CcSEcCtD
Gadobutrol—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00316	0.00316	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.00315	0.00315	CcSEcCtD
Gadobutrol—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.00313	0.00313	CcSEcCtD
Gadobutrol—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00313	0.00313	CcSEcCtD
Gadobutrol—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00312	0.00312	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.00311	0.00311	CcSEcCtD
Gadobutrol—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.0031	0.0031	CcSEcCtD
Gadobutrol—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.0031	0.0031	CcSEcCtD
Gadobutrol—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00307	0.00307	CcSEcCtD
Gadobutrol—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00307	0.00307	CcSEcCtD
Gadobutrol—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00306	0.00306	CcSEcCtD
Gadobutrol—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00306	0.00306	CcSEcCtD
Gadobutrol—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00305	0.00305	CcSEcCtD
Gadobutrol—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.00305	0.00305	CcSEcCtD
Gadobutrol—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00305	0.00305	CcSEcCtD
Gadobutrol—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00305	0.00305	CcSEcCtD
Gadobutrol—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00304	0.00304	CcSEcCtD
Gadobutrol—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.00303	0.00303	CcSEcCtD
Gadobutrol—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00301	0.00301	CcSEcCtD
Gadobutrol—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00301	0.00301	CcSEcCtD
Gadobutrol—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.00301	0.00301	CcSEcCtD
Gadobutrol—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.00301	0.00301	CcSEcCtD
Gadobutrol—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.003	0.003	CcSEcCtD
Gadobutrol—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.003	0.003	CcSEcCtD
Gadobutrol—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00299	0.00299	CcSEcCtD
Gadobutrol—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00294	0.00294	CcSEcCtD
Gadobutrol—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00289	0.00289	CcSEcCtD
Gadobutrol—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.00288	0.00288	CcSEcCtD
Gadobutrol—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.00287	0.00287	CcSEcCtD
Gadobutrol—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.00287	0.00287	CcSEcCtD
Gadobutrol—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00287	0.00287	CcSEcCtD
Gadobutrol—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00285	0.00285	CcSEcCtD
Gadobutrol—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00285	0.00285	CcSEcCtD
Gadobutrol—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00284	0.00284	CcSEcCtD
Gadobutrol—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00282	0.00282	CcSEcCtD
Gadobutrol—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00282	0.00282	CcSEcCtD
Gadobutrol—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00282	0.00282	CcSEcCtD
Gadobutrol—Rash—Didanosine—acquired immunodeficiency syndrome	0.0028	0.0028	CcSEcCtD
Gadobutrol—Infection—Delavirdine—acquired immunodeficiency syndrome	0.0028	0.0028	CcSEcCtD
Gadobutrol—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.0028	0.0028	CcSEcCtD
Gadobutrol—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.0028	0.0028	CcSEcCtD
Gadobutrol—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.0028	0.0028	CcSEcCtD
Gadobutrol—Headache—Didanosine—acquired immunodeficiency syndrome	0.00278	0.00278	CcSEcCtD
Gadobutrol—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00278	0.00278	CcSEcCtD
Gadobutrol—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00277	0.00277	CcSEcCtD
Gadobutrol—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00276	0.00276	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00274	0.00274	CcSEcCtD
Gadobutrol—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00273	0.00273	CcSEcCtD
Gadobutrol—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00272	0.00272	CcSEcCtD
Gadobutrol—Pain—Indinavir—acquired immunodeficiency syndrome	0.00267	0.00267	CcSEcCtD
Gadobutrol—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00266	0.00266	CcSEcCtD
Gadobutrol—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00266	0.00266	CcSEcCtD
Gadobutrol—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00266	0.00266	CcSEcCtD
Gadobutrol—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00265	0.00265	CcSEcCtD
Gadobutrol—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00265	0.00265	CcSEcCtD
Gadobutrol—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00265	0.00265	CcSEcCtD
Gadobutrol—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00265	0.00265	CcSEcCtD
Gadobutrol—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00264	0.00264	CcSEcCtD
Gadobutrol—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00264	0.00264	CcSEcCtD
Gadobutrol—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00263	0.00263	CcSEcCtD
Gadobutrol—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00263	0.00263	CcSEcCtD
Gadobutrol—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.0026	0.0026	CcSEcCtD
Gadobutrol—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00256	0.00256	CcSEcCtD
Gadobutrol—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00256	0.00256	CcSEcCtD
Gadobutrol—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00255	0.00255	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00255	0.00255	CcSEcCtD
Gadobutrol—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00255	0.00255	CcSEcCtD
Gadobutrol—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00254	0.00254	CcSEcCtD
Gadobutrol—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00254	0.00254	CcSEcCtD
Gadobutrol—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00253	0.00253	CcSEcCtD
Gadobutrol—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00252	0.00252	CcSEcCtD
Gadobutrol—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00252	0.00252	CcSEcCtD
Gadobutrol—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00252	0.00252	CcSEcCtD
Gadobutrol—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00252	0.00252	CcSEcCtD
Gadobutrol—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00251	0.00251	CcSEcCtD
Gadobutrol—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00251	0.00251	CcSEcCtD
Gadobutrol—Headache—Nevirapine—acquired immunodeficiency syndrome	0.0025	0.0025	CcSEcCtD
Gadobutrol—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00249	0.00249	CcSEcCtD
Gadobutrol—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00246	0.00246	CcSEcCtD
Gadobutrol—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00246	0.00246	CcSEcCtD
Gadobutrol—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00246	0.00246	CcSEcCtD
Gadobutrol—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00245	0.00245	CcSEcCtD
Gadobutrol—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00244	0.00244	CcSEcCtD
Gadobutrol—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00244	0.00244	CcSEcCtD
Gadobutrol—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00244	0.00244	CcSEcCtD
Gadobutrol—Rash—Stavudine—acquired immunodeficiency syndrome	0.00243	0.00243	CcSEcCtD
Gadobutrol—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00243	0.00243	CcSEcCtD
Gadobutrol—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00243	0.00243	CcSEcCtD
Gadobutrol—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00242	0.00242	CcSEcCtD
Gadobutrol—Headache—Stavudine—acquired immunodeficiency syndrome	0.00242	0.00242	CcSEcCtD
Gadobutrol—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00242	0.00242	CcSEcCtD
Gadobutrol—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00241	0.00241	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00241	0.00241	CcSEcCtD
Gadobutrol—Rash—Abacavir—acquired immunodeficiency syndrome	0.0024	0.0024	CcSEcCtD
Gadobutrol—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00239	0.00239	CcSEcCtD
Gadobutrol—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00239	0.00239	CcSEcCtD
Gadobutrol—Headache—Abacavir—acquired immunodeficiency syndrome	0.00238	0.00238	CcSEcCtD
Gadobutrol—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00238	0.00238	CcSEcCtD
Gadobutrol—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00237	0.00237	CcSEcCtD
Gadobutrol—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.00236	0.00236	CcSEcCtD
Gadobutrol—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.00234	0.00234	CcSEcCtD
Gadobutrol—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00233	0.00233	CcSEcCtD
Gadobutrol—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00233	0.00233	CcSEcCtD
Gadobutrol—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00232	0.00232	CcSEcCtD
Gadobutrol—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00231	0.00231	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.0023	0.0023	CcSEcCtD
Gadobutrol—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.0023	0.0023	CcSEcCtD
Gadobutrol—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.0023	0.0023	CcSEcCtD
Gadobutrol—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00229	0.00229	CcSEcCtD
Gadobutrol—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00229	0.00229	CcSEcCtD
Gadobutrol—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.00227	0.00227	CcSEcCtD
Gadobutrol—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00226	0.00226	CcSEcCtD
Gadobutrol—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00225	0.00225	CcSEcCtD
Gadobutrol—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00224	0.00224	CcSEcCtD
Gadobutrol—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00223	0.00223	CcSEcCtD
Gadobutrol—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.00223	0.00223	CcSEcCtD
Gadobutrol—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00223	0.00223	CcSEcCtD
Gadobutrol—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00222	0.00222	CcSEcCtD
Gadobutrol—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00217	0.00217	CcSEcCtD
Gadobutrol—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00216	0.00216	CcSEcCtD
Gadobutrol—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00215	0.00215	CcSEcCtD
Gadobutrol—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00215	0.00215	CcSEcCtD
Gadobutrol—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00213	0.00213	CcSEcCtD
Gadobutrol—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00213	0.00213	CcSEcCtD
Gadobutrol—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00213	0.00213	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00213	0.00213	CcSEcCtD
Gadobutrol—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00211	0.00211	CcSEcCtD
Gadobutrol—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00211	0.00211	CcSEcCtD
Gadobutrol—Headache—Zidovudine—acquired immunodeficiency syndrome	0.0021	0.0021	CcSEcCtD
Gadobutrol—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00208	0.00208	CcSEcCtD
Gadobutrol—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00206	0.00206	CcSEcCtD
Gadobutrol—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00206	0.00206	CcSEcCtD
Gadobutrol—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00206	0.00206	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00205	0.00205	CcSEcCtD
Gadobutrol—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00205	0.00205	CcSEcCtD
Gadobutrol—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00202	0.00202	CcSEcCtD
Gadobutrol—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00199	0.00199	CcSEcCtD
Gadobutrol—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00198	0.00198	CcSEcCtD
Gadobutrol—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00198	0.00198	CcSEcCtD
Gadobutrol—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00198	0.00198	CcSEcCtD
Gadobutrol—Rash—Indinavir—acquired immunodeficiency syndrome	0.00197	0.00197	CcSEcCtD
Gadobutrol—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00196	0.00196	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00196	0.00196	CcSEcCtD
Gadobutrol—Headache—Indinavir—acquired immunodeficiency syndrome	0.00195	0.00195	CcSEcCtD
Gadobutrol—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00195	0.00195	CcSEcCtD
Gadobutrol—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00193	0.00193	CcSEcCtD
Gadobutrol—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00192	0.00192	CcSEcCtD
Gadobutrol—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00189	0.00189	CcSEcCtD
Gadobutrol—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00189	0.00189	CcSEcCtD
Gadobutrol—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00187	0.00187	CcSEcCtD
Gadobutrol—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00186	0.00186	CcSEcCtD
Gadobutrol—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00186	0.00186	CcSEcCtD
Gadobutrol—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00186	0.00186	CcSEcCtD
Gadobutrol—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00185	0.00185	CcSEcCtD
Gadobutrol—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00185	0.00185	CcSEcCtD
Gadobutrol—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00185	0.00185	CcSEcCtD
Gadobutrol—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00179	0.00179	CcSEcCtD
Gadobutrol—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00178	0.00178	CcSEcCtD
Gadobutrol—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00178	0.00178	CcSEcCtD
Gadobutrol—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00178	0.00178	CcSEcCtD
Gadobutrol—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00177	0.00177	CcSEcCtD
Gadobutrol—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00176	0.00176	CcSEcCtD
Gadobutrol—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00175	0.00175	CcSEcCtD
Gadobutrol—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00172	0.00172	CcSEcCtD
Gadobutrol—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00172	0.00172	CcSEcCtD
Gadobutrol—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00167	0.00167	CcSEcCtD
Gadobutrol—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00166	0.00166	CcSEcCtD
Gadobutrol—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00166	0.00166	CcSEcCtD
Gadobutrol—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00164	0.00164	CcSEcCtD
Gadobutrol—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00164	0.00164	CcSEcCtD
Gadobutrol—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00164	0.00164	CcSEcCtD
Gadobutrol—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00163	0.00163	CcSEcCtD
Gadobutrol—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.0016	0.0016	CcSEcCtD
Gadobutrol—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00158	0.00158	CcSEcCtD
Gadobutrol—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00158	0.00158	CcSEcCtD
Gadobutrol—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00158	0.00158	CcSEcCtD
Gadobutrol—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00157	0.00157	CcSEcCtD
Gadobutrol—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00155	0.00155	CcSEcCtD
Gadobutrol—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00152	0.00152	CcSEcCtD
Gadobutrol—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00151	0.00151	CcSEcCtD
Gadobutrol—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00151	0.00151	CcSEcCtD
Gadobutrol—Headache—Lamivudine—acquired immunodeficiency syndrome	0.0015	0.0015	CcSEcCtD
Gadobutrol—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00149	0.00149	CcSEcCtD
Gadobutrol—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00142	0.00142	CcSEcCtD
